
Morning Notes — Identifiable Risk
JNJ efficacy data in the 80% range would further weigh on fiscal stimulus expectations that already appear challenged. Markets had assumed that Biden’s ~$1.9T stimulus proposal would be pared back to something closer to ~$900B with full passage likely by the end of February.